关注
Jorge S. Valadas
Jorge S. Valadas
Muna Therapeutics
在 munatherapeutics.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Adenosine A2A receptor blockade reverts hippocampal stress-induced deficits and restores corticosterone circadian oscillation
VL Batalha, JM Pêgo, BM Fontinha, AR Costenla, JS Valadas, Y Baqi, ...
Molecular psychiatry 18 (3), 320-331, 2013
1592013
Overexpression of Adenosine A2A Receptors in Rats: Effects on Depression, Locomotion, and Anxiety
JE Coelho, P Alves, PM Canas, JS Valadas, T Shmidt, VL Batalha, ...
Frontiers in psychiatry 5, 67, 2014
1152014
ER Lipid Defects in Neuropeptidergic Neurons Impair Sleep Patterns in Parkinson’s Disease
JS Valadas, G Esposito, D Vandekerkhove, K Miskiewicz, L Deaulmerie, ...
Neuron, 2018
972018
Aconitase Causes Iron Toxicity in Drosophila pink1 Mutants
G Esposito, M Vos, S Vilain, J Swerts, J De Sousa Valadas, ...
Plos genetics 9 (4), e1003478, 2013
752013
The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function
VL Batalha, DG Ferreira, JE Coelho, JS Valadas, R Gomes, ...
Scientific Reports 6 (1), 31493, 2016
612016
Therapeutic strategies in Parkinson's disease: what we have learned from animal models
JS Valadas, M Vos, P Verstreken
Annals of the New York Academy of Sciences 1338 (1), 16-37, 2015
472015
HDAC6 is a Bruchpilot deacetylase that facilitates neurotransmitter release
K Miskiewicz, LE Jose, WM Yeshaw, JS Valadas, J Swerts, S Munck, ...
Cell Reports 8 (1), 94-102, 2014
432014
Escitalopram improves memory deficits induced by maternal separation in the rat
FS do Couto, VL Batalha, JS Valadas, J Data-Franca, JA Ribeiro, ...
European journal of pharmacology 695 (1-3), 71-75, 2012
422012
Neuroprotection afforded by adenosine A2A receptor blockade is modulated by corticotrophin‐releasing factor (CRF) in glutamate injured cortical neurons
JS Valadas, VL Batalha, DG Ferreira, R Gomes, JE Coelho, AM Sebastião, ...
Journal of neurochemistry 123 (6), 1030-1040, 2012
362012
MAPRE2 mutations result in altered human cranial neural crest migration, underlying craniofacial malformations in CSC-KT syndrome
C Thues, JS Valadas, L Deaulmerie, A Geens, AK Chouhan, ...
Scientific Reports 11 (1), 4976, 2021
122021
Divergent functional outcomes of NLRP3 blockade downstream of multi-inflammasome activation: Therapeutic implications for ALS
ML Clénet, J Keaney, G Gillet, JS Valadas, J Langlois, A Cardenas, ...
Frontiers in Immunology 14, 1190219, 2023
22023
Innate immune activation and aberrant function in the R6/2 mouse model and Huntington’s disease iPSC-derived microglia
J Gasser, G Gillet, JS Valadas, L Rouvière, A Kotian, W Fan, J Keaney, ...
Frontiers in molecular neuroscience 16, 1191324, 2023
12023
p13 protects against Parkinson's disease
JS Valadas, P Verstreken
EMBO reports 19 (3), e45900, 2018
12018
An improved method for large scale generation and high-throughput functional characterization of human iPSC-derived microglia
M Padmakumar, S Biesmans, JS Valadas, JR Detrez, G Gillet, P Bresler, ...
Frontiers in Drug Discovery 3, 1289314, 2023
2023
p13 protects against Parkinson's disease
J De Sousa Valadas, P Verstreken
EMBO Reports 19 (3), 2018
2018
系统目前无法执行此操作,请稍后再试。
文章 1–15